We are live on ! Find out more
Ray Dalio

Ray Dalio Bridgewater Associates

AUM $22.4B
1-Year Est. Return 34.48%
 

Ray Dalio is the founder of Bridgewater Associates, one of the world’s largest hedge funds, known for its unique “principles-based” culture and systematic investment approach. Dalio’s investment philosophy emphasizes diversified portfolios, risk parity, and the importance of understanding economic cycles in shaping investment decisions. He has authored several books, including “Principles: Life & Work,” in which he details his management philosophies, personal experiences, and life lessons.

This Fund
S&P 500
This Quarter Est. Return
+4.3%
1 Year Est. Return
+34.48%
3 Year Est. Return
+84.29%
5 Year Est. Return
+89.92%
10 Year Est. Return
+230.06%
AUM
$27.4B
AUM Growth
+$1.89B
Cap. Flow
+$1.36B
Cap. Flow %
4.94%
Top 10 Hldgs %
36.33%
Holding
1,205
New
191
Increased
450
Reduced
395
Closed
165

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.28B
2
ORCL icon
Oracle
ORCL
+$349M
3
NVDA icon
NVIDIA
NVDA
+$252M
4
MU icon
Micron Technology
MU
+$204M
5
AMZN icon
Amazon
AMZN
+$188M

Sector Composition

Rank Sector Weight
1 Technology 28.43%
2 Financials 11.06%
3 Consumer Discretionary 8.45%
4 Healthcare 6.54%
5 Industrials 6.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASH icon
1051
Ashland
ASH
$3.5B
-17,588
Closed -$843K
ASTS icon
1052
AST SpaceMobile
ASTS
$21.5B
-13,741
Closed -$674K
ATI icon
1053
ATI
ATI
$31.1B
-136,458
Closed -$11.1M
ATR icon
1054
AptarGroup
ATR
$8.61B
-18,568
Closed -$2.48M
AVA icon
1055
Avista
AVA
$3.24B
-5,469
Closed -$207K
AVAV icon
1056
AeroVironment
AVAV
$9.45B
-11,349
Closed -$3.57M
AYI icon
1057
Acuity Brands
AYI
$10.8B
-18,781
Closed -$6.47M
AZN icon
1058
AstraZeneca
AZN
$250B
-231,430
Closed -$35.5M
BA icon
1059
Boeing
BA
$185B
-6,453
Closed -$1.39M
BCC icon
1060
Boise Cascade
BCC
$3.02B
-4,429
Closed -$342K
BHF icon
1061
Brighthouse Financial
BHF
$3.49B
-60,339
Closed -$3.2M
BHVN icon
1062
Biohaven
BHVN
$2.21B
-20,060
Closed -$301K
BIIB icon
1063
Biogen
BIIB
$30.7B
-39,983
Closed -$5.6M
BIO icon
1064
Bio-Rad Laboratories Class A
BIO
$9.42B
-10,632
Closed -$2.98M
BKE icon
1065
Buckle
BKE
$2.37B
-71,008
Closed -$4.17M
BKSY icon
1066
BlackSky Technology
BKSY
$1.19B
-14,879
Closed -$300K
BLDR icon
1067
Builders FirstSource
BLDR
$8.04B
-27,324
Closed -$3.31M
BSY icon
1068
Bentley Systems
BSY
$10.7B
-93,424
Closed -$4.81M
CAE icon
1069
CAE Inc. Common Shares
CAE
$8.74B
-12,163
Closed -$360K
CARR icon
1070
Carrier Global
CARR
$52.8B
-134,658
Closed -$8.04M
CBSH icon
1071
Commerce Bancshares
CBSH
$8.5B
-96,217
Closed -$5.48M
CCJ icon
1072
Cameco
CCJ
$42.4B
-293,928
Closed -$24.7M
CERT icon
1073
Certara
CERT
$1.25B
-19,122
Closed -$234K
CGAU
1074
Centerra Gold
CGAU
$4.15B
-31,139
Closed -$334K
CHDN icon
1075
Churchill Downs
CHDN
$6.12B
-29,631
Closed -$2.87M

Similar funds

Ray Dalio's Q4 2025 Portfolio in Review

As of Q4 2025, Ray Dalio held 1,205 positions worth $27.4B, up 7.4% from $25.5B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Ray Dalio deployed $1.36B of net new capital in Q4 2025, opening 191 new positions and adding to 450 existing holdings. Its largest new stake was Arm: 326,320 shares worth $35.7M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 29% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $304M trimmed.

  • Ray Dalio's largest Q4 2025 buy was Arm: 326,320 shares worth $35.7M.
  • Ray Dalio added most to State Street SPDR S&P 500 ETF Trust in Q4 2025, an estimated $1.28B increase.
  • Ray Dalio's biggest Q4 2025 reduction was Alphabet (Google) Class A, cutting an estimated $304M.
  • Ray Dalio fully exited Fiserv Inc in Q4 2025, selling an estimated $205M.
  • Ray Dalio's ten largest holdings make up 36% of its $27.4B portfolio in Q4 2025.
  • Ray Dalio opened 191 new positions and closed 165 in Q4 2025.
  • Ray Dalio's portfolio value rose 7.4% quarter-over-quarter to $27.4B.

Based on Bridgewater Associates's 13F filing for Q4 2025, filed 13 Feb 2026.